Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeSt for kids in juvenile idiopathic arthritis
NL-OMON38311Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methotrexate, etanercept and caffeine in juvenile idiopathic arthritis (JIA) and juvenile psoriatic arthritis (JPsA) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Time to inactive disease and Time to flare. Started Oct 2009; status: active, not recruiting.
02
Drugs
methotrexateetanerceptcaffeine
03
Conditions
juvenile idiopathic arthritis (JIA)juvenile psoriatic arthritis (JPsA)
Beyond the preview
Go deeper on NL-OMON38311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38311.